We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Europe’s Remdesivir Shortage Prompts Gilead Supply Deal
The European Commission has inked a supply deal with Gilead Sciences for 500,000 courses of the company’s antiviral drug remdesivir to shore up Europe’s depleting stocks of the COVID-19 treatment.